Access cutting-edge respiratory syncytial virus treatment through this clinical trial at a research site in Covington. Study-provided care at no cost to qualified participants.
Access respiratory syncytial virus specialists in Covington at no cost
This study follows strict safety protocols and ethical guidelines
All study-related respiratory syncytial virus treatment provided free
The purpose of this study is to evaluate safety, tolerability and immunogenicity of mRNA-1345 in participants who have been previously vaccinated with either Arexvy or Abrysvo at least 12 months prior to enrollment, are medically stable and aged ≥60 years.
Sponsor: ModernaTX, Inc.
Check if you qualify for this respiratory syncytial virus clinical trial in Covington, LA
If you're searching for respiratory syncytial virus treatment options in Covington, LA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Covington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced respiratory syncytial virus specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.